Oncotarget, 2017 Sep 14
Nabil Adra, MD
Assistant Professor of Clinical Medicine
535 Barnhill Drive, RT 473
Indianapolis, IN 46202
2017 BS Biology, General, American University Of Beirut
2017 MD Medicine (M.D.), American University Of Beirut
Phase II Trial of Pembrolizumab in Patients with Platinum Refractory Germ Cell Tumors: A Hoosier Cancer Research Network Study GU14-206.
Annals of oncology : official journal of the European Society for Medical Oncology, 2017 Oct 17
Multidisciplinary Clinic Approach Improves Overall Survival Outcomes of Patients with Metastatic Germ Cell Tumors.
Annals of oncology : official journal of the European Society for Medical Oncology, 2017 Nov 10
Clinical advances in hematology & oncology : H&O, 2017 May
Clinical genitourinary cancer, 2017 Feb 1
High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016 Nov 21
, 2016 Mar
Prognostic factors in patients with poor-risk germ-cell tumors: a retrospective analysis of the Indiana University experience from 1990 to 2014.
, 2016 Feb 9
Phase II study of fosaprepitant?+?5HT3 receptor antagonist?+?dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study.
, 2016 Feb 2
Clinical genitourinary cancer, 2016 Dec 29
A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors.
, 2016 Aug 8
American Board of Internal Medicine - Internal Medicine